Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
4-Aryl-1,4-Dihydropyridines as Potential Enoyl-Acyl Carrier Protein Reductase Inhibitors: Antitubercular Activity and Molecular Docking Study.
Venugopala KN, Deb PK, Pillay M, Chopra D, Chandrashekharappa S, Morsy MA, Aldhubiab BE, Attimarad M, Nair AB, Sreeharsha N, Kandeel M, Venugopala R, Mohanlall V. Venugopala KN, et al. Among authors: deb pk. Curr Top Med Chem. 2021;21(4):295-306. doi: 10.2174/1568026620666201102121606. Curr Top Med Chem. 2021. PMID: 33138763
Current Scenario and Future Prospect in the Management of COVID-19.
Borah P, Deb PK, Deka S, Venugopala KN, Singh V, Mailavaram RP, Kalia K, Tekade RK. Borah P, et al. Among authors: deb pk. Curr Med Chem. 2021;28(2):284-307. doi: 10.2174/0929867327666200908113642. Curr Med Chem. 2021. PMID: 32900341 Review.
Imidazo[1,2-a]pyridine Scaffold as Prospective Therapeutic Agents.
Deep A, Bhatia RK, Kaur R, Kumar S, Jain UK, Singh H, Batra S, Kaushik D, Deb PK. Deep A, et al. Among authors: deb pk. Curr Top Med Chem. 2017;17(2):238-250. doi: 10.2174/1568026616666160530153233. Curr Top Med Chem. 2017. PMID: 27237332 Review.
110 results